Investigator site

Cologne 50973

0 studies enrolling now · 3 studies all time

What they study most

Acquired Thrombotic Thrombocytopenic Purpura, Rheumatoid Arthritis

Studies at this site

• Phase III Trial With Caplacizumab in Patients With Acquired Thrombotic Thrombocytopenic Purpura — Completed
• Study to Assess Efficacy and Safety of Anti-von Willebrand Factor (vWF) Nanobody in Patients With Acquired Thrombotic Thrombocytopenic Purpura (aTTP) — Completed
• A Dose-Range Finding Study for ALX-0061 Combination Therapy in Subjects With Rheumatoid Arthritis — Completed